Omega Therapeutics (NASDAQ:OMGA) Downgraded to "Hold" at Zac

Omega Therapeutics (NASDAQ:OMGA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Omega Therapeutics Inc. is a development-stage biotechnology company. Its OMEGA Epigenomic Programming(TM) platform harness the power of epigenetics to develop a new class of […]

Related Keywords

California , United States , Cambridge , Cambridgeshire , United Kingdom , American , Piper Sandler , Omega Therapeutics Inc , Cubist Systematic Strategies , Zacks Investment Research , American International Group Inc , Deutsche Bank , Citigroup Inc , Nasdaq , Omega Therapeutics , Get Rating , Systematic Strategies , State Teachers Retirement System , International Group , Nasdaq Omga , Komga , Medical , Downgrade ,